Legal & General Group’s VYNE Therapeutics VYNE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3,220
| Closed | -$22K | – | 3657 |
|
|
2021
Q1 | $22K | Sell |
3,220
-9,664
| -75% | -$66K | ﹤0.01% | 3106 |
|
|
2020
Q4 | $20K | Hold |
12,884
| – | – | ﹤0.01% | 3095 |
|
|
2020
Q3 | $21K | Sell |
12,884
-1,225
| -9% | -$2K | ﹤0.01% | 2959 |
|
|
2020
Q2 | $24K | Buy |
14,109
+8,034
| +132% | +$13.7K | ﹤0.01% | 2990 |
|
|
2020
Q1 | $16K | Buy |
6,075
+3,433
| +130% | +$9.04K | ﹤0.01% | 3004 |
|
|
2019
Q4 | $12K | Hold |
2,642
| – | – | ﹤0.01% | 3272 |
|
|
2019
Q3 | $12K | Hold |
2,642
| – | – | ﹤0.01% | 3245 |
|
|
2019
Q2 | $16K | Buy |
2,642
+1,513
| +134% | +$9.16K | ﹤0.01% | 3269 |
|
|
2019
Q1 | $9K | Hold |
1,129
| – | – | ﹤0.01% | 3264 |
|
|
2018
Q4 | $5K | Hold |
1,129
| – | – | ﹤0.01% | 3338 |
|
|
2018
Q3 | $11K | Hold |
1,129
| – | – | ﹤0.01% | 3315 |
|
|
2018
Q2 | $9K | Hold |
1,129
| – | – | ﹤0.01% | 3313 |
|
|
2018
Q1 | $43K | Buy |
+1,129
| New | +$43K | ﹤0.01% | 2826 |
|